INTRODUCING WILDTYPE TP53 IN TP53 MUTATED MYELOID LEUKEMIAS IMPROVES SENSITIVITY TO CHEMOTHERAPEUTIC DRUGS

被引：0
|
作者：
Maity, Arnab [1 ,2 ]
Illangeswaran, Raveen [3 ]
Rajamani, Bharathi [3 ]
Choudhury, Anurag [3 ]
Velayudhan, Shaji [4 ]
Kulkarni, Uday
Balasubramanian, Poonkuzhaki [3 ]
机构：
[1] Christian Med Coll Vellore, Kilminnal Village, India
[2] Reg Ctr Biotechnol Faridabad, Kilminnal Village, India
[3] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India
[4] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India
来源：
EXPERIMENTAL HEMATOLOGY | 2024年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3123
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Racial disparities in patients with TP53 mutated acute myeloid leukemia.
    Badar, Talha
    Litzow, Mark Robert
    Shallis, Rory
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Saliba, Antoine N.
    Correia, Guilherme Sacchi De Camargo
    Patel, Anand Ashwin
    Abaza, Yasmin
    Murthy, Guru Subramanian Guru
    Duvall, Adam
    Burkart, Madelyn
    Al-Kali, Aref
    Palmisiano, Neil
    Dinner, Shira
    Goldberg, Aaron David
    Atallah, Ehab L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19007 - E19007
  • [22] Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Cluzeau, Thomas
    Loschi, Michael
    Fenaux, Pierre
    Komrokji, Rami
    Sallman, David A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [23] Restoration of mutant TP53 to normal TP53 function by glycerol as a chemical chaperone
    Ohnishi, T
    Ohnishi, K
    Wang, XJ
    Takahashi, A
    Okaichi, K
    RADIATION RESEARCH, 1999, 151 (04) : 498 - 500
  • [24] Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
    Trauernicht, Max
    Rastogi, Chaitanya
    Manzo, Stefano G.
    Bussemaker, Harmen J.
    van Steensel, Bas
    NUCLEIC ACIDS RESEARCH, 2023, 51 (18) : 9690 - 9702
  • [25] Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER, 2012, 118 (05) : 1387 - 1396
  • [26] TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
    Ruzinova, Marianna B.
    Lee, Yi-Shan
    Duncavage, Eric J.
    Welch, John S.
    HAEMATOLOGICA, 2019, 104 (08) : E345 - E348
  • [27] Genomic Context and TP53 Allele Frequency Define Prognostic Subgroups and Response Outcomes in TP53 Mutated Myelodysplastic Syndromes
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Benton, Christopher B.
    Class, Caleb
    Chien, Kelly S.
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    Daver, Naval G.
    Takahashi, Koichi
    DiNardo, Courtney D.
    Jabbour, Elias
    Borthakur, Gautam M.
    Pemmaraju, Naveen
    Konopleva, Marina Y.
    Pierce, Sherry A.
    Bueso-Ramos, Carlos E.
    Andreeff, Michael
    Patel, Keyur P.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2019, 134
  • [28] TP53 and ovarian cancer
    Schuijer, M
    Berns, EMJJ
    HUMAN MUTATION, 2003, 21 (03) : 285 - 291
  • [29] TP53: an oncogene in disguise
    Soussi, T.
    Wiman, K. G.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (08): : 1239 - 1249
  • [30] TP53 in Myelodysplastic Syndromes
    Jiang, Yan
    Gao, Su-Jun
    Soubise, Benoit
    Douet-Guilbert, Nathalie
    Liu, Zi-Ling
    Troadec, Marie-Berengere
    CANCERS, 2021, 13 (21)
12345